Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2457 results about "Therapy medication" patented technology

Multifunctional hydrogel and application thereof

The invention discloses multifunctional hydrogel and application thereof, and belongs to the technical field of biological medicine. According to the multifunctional hydrogel, ketal mercaptan with two hydrazide ends and oxidized dextran are cross-linked to form a cross-linked network containing dynamic covalent bonds. The preparation method comprises the following steps: dissolving ketal mercaptan with two hydrazide ends in deionized water to obtain a ketal mercaptan solution, dissolving oxidized dextran in deionized water to obtain an oxidized dextran solution, mixing the ketal mercaptan solution with the oxidized dextran solution, and standing to obtain the multifunctional hydrogel. The multifunctional hydrogel has pH / ROS dual responsiveness, can respond to inflammation microenvironment and low pH of infectious wounds, remove active oxygen, release therapeutic drugs, regulate macrophage polarization and relieve bacterial infection, thereby playing a key role in inflammation, proliferation and remodeling stages of wound healing to accelerate wound healing. The curcumin-encapsulated liposome is added into the multifunctional hydrogel, so that the antibacterial effect can be further improved.
Owner:WEIFANG MEDICAL UNIV

Pharmaceutical composition and application thereof

The present invention discloses a pharmaceutical composition comprising a circular RNA and a drug delivery carrier. Compared with traditional linear 1 * siRNA and annular 1 * siRNA, the number of repeated series connection of positive-sense strands is increased to include but not limited to two or more, it is accidentally found that the silence effect is remarkably enhanced, the expression level of the PCSK9 gene can be remarkably reduced, and degradation of mRNA of PCSK9 protein is mediated. The nano-particles are used for delivering oligonucleotide, so that the stability is improved, the immunogenicity is reduced, the effects of lowering cholesterol, reducing aortic plaque load and resisting atherosclerosis are improved, and the nano-particles are safe and free of obvious liver and kidney toxicity and have a wide application prospect in the aspect of preparing medicines for treating hypercholesterolemia and coronary heart disease.
Owner:SUN YAT SEN MEMORIAL HOSPITAL SUN YAT SEN UNIV

Medical developing marker and manufacturing method thereof

The invention discloses a medical developing marker and a manufacturing method thereof, and relates to the field of medical instruments, the medical developing marker comprises a closed tube, the outer wall of the closed tube is provided with a bionic barb structure, the bionic barb structure is distributed in a flexible zigzag convex manner, and the bionic barb structure and the closed tube are integrally formed through an injection molding process; a closed cavity is arranged in the closed tube, four developing strips are symmetrically arranged in the tube wall of the closed cavity, the tube wall of the region where the developing strips are located is etched to form a weak band, and a developing material layer and a sustained-release medicine layer are sequentially deposited at the weak band. The developing material layer and the sustained-release drug and / or marked nano-particle layer are alternately deposited to form a functional composite layer, and the functional composite layer can directionally rupture to release the therapeutic drug under the action of implantation pressure. The marker integrates the functions of precise development, tissue anchoring and drug sustained release, is adaptive to multi-mode imaging such as ultrasonic imaging, X-ray imaging, CT imaging, MRI imaging and PET-CT imaging, and has remarkable clinical value in precise positioning treatment of solid tumors such as breast cancer and liver cancer.
Owner:SUN YAT SEN UNIVERSITY CANCER CENTER (CANCER HOSPITAL AFFILIATED TO SUN YAT SEN UNIVERSITY CANCER RESEARCH INSTITUTE OF SUN YAT SEN UNIVERSITY) +1

Construction method and equipment of predictive cell aging model, medium and program product

The invention provides a construction method of a predictive cell senescence model, a method for predicting the senescence state of a tissue sample based on the senescence model, a method for screening potential therapeutic drugs, equipment, a medium and a program product, and relates to the field of intelligent medical treatment. The model construction method comprises the following steps: acquiring a training set sample expression profile data set; identifying a key senescence gene set from the data set by using a feature selection algorithm; inputting the key senescence gene set into a machine learning model to fit a prediction model, and determining an optimal hyper-parameter to obtain a cell senescence model containing the weight of a single gene in the key senescence gene set; the cell senescence model is a senescence score obtained by calculating the sum of the product of the expression quantity of a single gene and the regression coefficient thereof. The cell senescence model, namely PreCSenM, is constructed by integrating a plurality of senescence characteristic gene sets and a gene scoring algorithm, the accuracy in CS evaluation is superior to that of 10 existing methods, and the application of CS from biological research to clinical scenes is also realized.
Owner:INSTITUTE OF BASIC MEDICAL SCIENCES CHINESE ACADEMY OF MEDICAL SCIENCES

Pharmaceutical composition and use thereof

Provided is a pharmaceutical composition, comprising a circular RNA and a drug delivery carrier. It is surprisingly found that compared with conventional linear 1 x siRNAs and circular 1 x siRNAs, increasing the number of tandem repeats in the sense strand to two or more significantly enhances the silencing effect, significantly reduces the expression level of the PCSK9 gene, and mediates the degradation of the PCSK9 protein mRNA. The use of nano-particles for delivering oligonucleotides features improved stability, reduced immunogenicity, improved cholesterol-lowering, aortic plaque load-reducing and anti-atherosclerotic effects, good safety, no significant liver and kidney toxicity, and therefore good prospects in preparing medicaments for treating hypercholesterolemia and a coronary heart disease.
Owner:SUN YAT SEN MEMORIAL HOSPITAL SUN YAT SEN UNIV

Polypeptide medicine for resisting gram-negative bacteria and application

The invention discloses a polypeptide drug for resisting gram-negative bacteria and application, and belongs to the technical field of biological medicine. The MIC of the antibacterial peptide obtained through screening on escherichia coli, salmonella typhimurium, pseudomonas aeruginosa, klebsiella pneumoniae, shigella sonnei and stenotrophomonas maltophilia is 16 [mu] g / mL, 2 [mu] g / mL, 16 [mu] g / mL, 4 [mu] g / mL, 2 [mu] g / mL and 4 [mu] g / mL respectively, and the antibacterial peptide has broad-spectrum antibacterial performance. The hemolytic activity and toxicity of the compound are lower than therapeutic concentration threshold values, and the compound can be used for preparing drugs or medical products for treating multi-drug-resistant bacterium infection.
Owner:SICHUAN UNIV

Neurosteroid derivative solid dispersion, preparation method and application thereof, and therapeutic drug for central nervous system disorder related diseases

The invention provides a neurosteroid derivative solid dispersion, a preparation method and application thereof, and a medicine containing a hot-melt extrusion solid dispersion, and belongs to the technical field of pharmacy. The preparation method comprises the following steps: carrying out melt extrusion on a raw material mixture at 125-160 DEG C to obtain the neurosteroid derivative solid dispersion, the mixed material comprises an active component, a plasticizer and a carrier material in a mass ratio of 10: (1-15): (10-90); the active component comprises at least one of a neurosteroid derivative (with a structure as shown in a formula 1), an isomer, a solvate and a pharmaceutically acceptable salt thereof; the plasticizer is selected from one or more of polyethylene glycol, poloxamer and Tween, and the average molecular weight of the polyethylene glycol is 1t; 6000, 6000; active components in the neurosteroid derivative solid dispersion exist in an amorphous state. The neurosteroid derivative in the neurosteroid derivative solid dispersion disclosed by the invention has relatively high oral bioavailability. # imgabs0 #
Owner:HUNAN MINGRUI PHARMACEUTICAL CO LTD

Application of lily extracellular vesicles in preparation of tumor treatment drugs

The invention belongs to the technical field of biological agents, and particularly discloses application of lily extracellular vesicles in preparation of tumor treatment drugs. The preparation method of the lily extracellular vesicles comprises the following steps: S1, juicing lily bulb tissues, and filtering to obtain a lily bulb stock solution; s2, treating the lily bulb stock solution obtained in the step S1 to obtain a lily extracellular vesicle extracting solution; s3, concentrating and purifying the lily extracellular vesicle extracting solution obtained in the step S2 to obtain lily extracellular vesicles; wherein in the step S2, the treatment comprises centrifugation and filter membrane filtration. The lily extracellular vesicle provided by the invention can effectively promote polarization of M2-type macrophages to M1-type macrophages, shows remarkable immunoregulation ability, is good in biocompatibility, and has the potential of preparing anti-cancer drugs.
Owner:ZHEJIANG SCI-TECH UNIV

Application of NR4A1 gene expression inhibitor in preparation of medicine for treating wine-dependent withdrawal

PendingCN119524128AReduce prefrontal apoptosis proteinReduce apoptotic proteinOrganic active ingredientsNervous disorderPrefrontal lobeApoptosis
The invention belongs to the technical field of biological medicines, and particularly relates to application of an expression inhibitor of an NR4A1 gene in preparation of a medicine for treating wine-dependent withdrawal. It is found that after wine-dependent withdrawal, mice have anxiety behaviors, the NR4A1 level of the prefrontal lobe is increased, and apoptosis-related protein in the prefrontal lobe is increased. Knockout of the forehead NR4A1 gene intervenes the expression level of the NR4A1 gene in the forehead lobe of the mouse, it can be proved that down-regulation of the expression of the forehead lobe NR4A1 gene can rescue apoptosis and damage, caused by alcohol, of cortical neurons of the forehead lobe, relieve anxiety behaviors caused by alcohol withdrawal of the mouse, and have the effect of protecting the brain of the mouse; the inhibitor DIM-C-pPhOH of the NR4A1 protein can reduce the expression of the NR4A1 gene of the prefrontal lobe of an alcohol withdrawal mouse and anxiety-like behaviors caused by alcohol withdrawal, and provides related therapeutic targets and new therapeutic drugs for anxiety dysfunction caused by clinical alcohol dependence and alcohol dependence withdrawal.
Owner:河南医药大学第二附属医院(河南省精神病医院)

Nano-drug delivery system capable of entering brain through nose and targeting central nervous system as well as preparation method and application of nano-drug delivery system

The invention relates to the technical field of biological medicine, and particularly discloses a nano-drug delivery system entering brain through nose and targeting central nervous and a preparation method and application thereof. The nano-drug delivery system capable of entering the brain through the nose and targeting the central nervous system comprises a biological treatment drug and lectin coupled liposome nano-particles wrapping the surface of the biological treatment drug, the biological treatment medicine is mRNA (messenger ribonucleic acid) coded biological macromolecules; the lectin is AAL, and the raw materials of the lipidosome nanoparticles comprise SM102, DSPC (Distearoyl Pyrrolidone), cholesterol, DMG-pSar25 and DSPE-PEG-MAL (Distearoyl Pyrrolidone-Polyethylene Glycol). According to the invention, AAL and LNP with specific components are coupled, so that specific recognition and binding with receptor fucose of target cells are realized, nano-materials are helped to be endocytosed through olfactory mucosa and delivered to the brain through a nasal-brain pathway, biological treatment drugs are delivered in a targeted manner, the blood-brain barrier is broken through, and the targeting efficiency and nasal delivery efficiency are remarkably improved.
Owner:TAIYI LIFE TECH (NINGBO) CO LTD

Intelligent tumor microenvironment analysis and drug screening method based on multi-modal data

The invention discloses an intelligent tumor microenvironment analysis and drug screening method based on multi-modal data, and relates to the field of tumor research. The method comprises the following steps: obtaining a plurality of prognosis image features according to preoperative magnetic resonance images of the brain of a plurality of glioblastoma patients; identifying a key image genomics gene set for each prognostic image feature; analyzing biological reasons of prognosis differences of high-risk patients and low-risk patients by using a transcriptome method; analyzing biological functions of prognosis image features; utilizing Fisher to accurately test and determine a cell population associated with the prognostic image features; determining a functional state of the cell population based on the scRNA-seq data of the cell population; constructing an image-gene-cell population-functional state association; potential therapeutic drugs for cell populations associated with prognostic image features are parsed using chi-square test. According to the invention, the tumor heterogeneity of glioblastoma can be depicted from the perspective of images, and potential therapeutic drugs can be identified.
Owner:HARBIN MEDICAL UNIVERSITY

Application of orifice-opening and deafness-removing pill in preparation of anti-dizziness drug

The invention relates to the technical field of medicines, in particular to novel application of orifice-opening and deafness-removing pills in preparation of anti-dizziness medicines. Experiments prove that the administration group can remarkably shorten the standing time consumption of a vertigo mouse caused by movement on the horizontal rod and reduce the vertigo response index, so that the movement vertigo model mouse can stand stably on the horizontal rod more quickly; abnormal changes of indexes such as ACTH, NE and CREB in mouse serum and BDNF, CREB, 5-HT and DA in brain caused by motion vertigo can be remarkably reversed. Therefore, the orifice-opening and deafness-removing pill has an obvious anti-dizziness effect, can be used as an active ingredient for preparing the anti-dizziness medicine, and is an effective treatment medicine especially for dizziness induced by movement. According to the invention, new indications of the orifice-opening and deafness-removing pill except deafness, tinnitus and otitis media are expanded. In anti-dizziness treatment, compared with dizziness stop, the traditional Chinese medicine composition can avoid digestive system reaction, cardiovascular reaction, central nervous system reaction and other side effects caused by dizziness stop.
Owner:HEBEI YONGFENG YAOYE

Compositions, devices, and methods for the treatment of overdose and reward-based disorders

Drug products adapted for nasal delivery, comprising a device filled with a pharmaceutical composition comprising naltrexone are provided. Formulations and methods of treating alcohol use disorder and related conditions with the drug products are also provided.
Owner:INDIVIOR UK LTD +1

Application of phenolic compound and / or pharmaceutically acceptable salt thereof in preparation of medicine for treating breast cancer, and pharmaceutical composition

The invention provides application of a phenolic compound and / or pharmaceutically acceptable salt thereof in preparation of a medicine for treating breast cancer and a pharmaceutical composition, and relates to the technical field of biological medicines. The invention discloses application of phenolic compounds and / or pharmaceutically acceptable salts thereof in preparation of medicines for treating breast cancer. The phenolic compounds comprise a compound 1 and / or a compound 2. The compound 1 (arnebidin) and the compound 2 ((+)-(R)-de-O-metalasiodiplodin) adopted in the invention have good inhibition effects on human triple-negative breast cancer MDA-MB-231 cell strains, the IC50 value of the compound 1 is 1.16 [mu] M, and the IC50 value of the compound 2 is 0.68 [mu] M, so that a new choice is provided for developing drugs for treating triple-negative breast cancer, and the compound 1 and the compound 2 have good application prospects. The compound has a good application prospect in preparation of medicines for treating breast cancer, especially medicines for treating triple-negative breast cancer.
Owner:INSTITUTE OF CHINESE MATERIA MEDICA CHINA ACADEMY OF CHINESE MEDICAL SCIENCES

ShRNA for knocking down BST2 gene expression, recombinant vector and application

The invention belongs to the technical field of gene engineering, and provides shRNA (short hairpin Ribonucleic Acid) for knocking down BST2 gene expression, a recombinant vector and application of the shRNA, and the shRNA comprises Bst2-shRNA-1 or Bst2-shRNA-2; the Bst2-shRNA-1 comprises a positive-sense strand of which the nucleotide sequence is as shown in SEQ ID NO. 1 and an antisense strand of which the nucleotide sequence is as shown in SEQ ID NO. 2; the Bst2-shRNA-2 comprises a positive-sense strand of which the nucleotide sequence is as shown in SEQ ID NO. 3 and an antisense strand of which the nucleotide sequence is as shown in SEQ ID NO. 4. The shRNA disclosed by the invention plays an important role in inhibiting non-infectious aseptic inflammation, can effectively delay the ALS attack time and protect motor neurons, has a very good application prospect, and also provides a direction and a technical basis for searching, researching and developing new therapeutic drugs for treating ALS.
Owner:CHIFENG MUNICIPAL HOSPITAL

Co-culture method of gastric cancer organs and gastric cancer related myofibroblasts and application of co-culture method

The invention discloses a co-culture method of gastric cancer organoid and gastric cancer-related myofibroblast and application of the co-culture method, gastric cancer organoid single-cell suspension and gastric cancer-related myofibroblast single-cell suspension are mixed according to the number ratio of 1: 1, then matrigel is added, after uniform mixing, the mixture is put into a CO2 cell incubator to solidify the matrigel, and the gastric cancer-related myofibroblast co-culture medium is obtained. The co-cultured gastric cancer organoid is faster in growth speed and stronger in resistance to chemotherapeutic drugs, the drug resistance of tumor cells in the body of a gastric cancer patient to the chemotherapeutic drugs is better simulated, and the co-cultured gastric cancer organoid can become a screening platform of individualized therapeutic drugs for tumor patients.
Owner:ARMY MEDICAL UNIV

Methods and compositions for treating drug overdose

Disclosed in certain embodiments is a method of treating a drug overdose comprising administering to a patient in need thereof a therapeutically effective amount of a respiratory stimulant, wherein the overdosed drug comprises an α2 adrenergic receptor agonist.
Owner:ENALARE THERAPEUTICS INC

Engineering bionic nucleic acid nano-vesicle as well as preparation method and application thereof

The invention discloses an engineered bionic nucleic acid nano-vesicle as well as a preparation method and application thereof, relates to the technical field of nano biomedicine, and aims at solving the problems that in-vivo targeting efficiency and immunogenicity of a traditional cationic lipid nano-carrier are limited due to deletion and cleavage obstacles of GSDMD expression in tumor cells. The technical key point of the invention is as follows: the engineered bionic nucleic acid nano-vesicle is provided and is prepared by wrapping a cationic lipid nucleic acid drug with an exosome derived from engineered macrophages; wherein the exosome from the engineered macrophage is the exosome from the macrophage with high expression of PD1, which is as shown in SEQ. ID. NO.1. The exosome from the engineered macrophage is the exosome from the macrophage with high expression of PD1; the lipid nucleic acid medicine is prepared by loading GSDMD-N mRNA (messenger Ribonucleic Acid) shown on the basis of SEQ.ID.NO.2 on a cationic liposome. The engineered bionic nucleic acid nano-vesicle is used for preparing an oral squamous cell carcinoma diagnostic kit and a therapeutic drug.
Owner:HARBIN MEDICAL UNIVERSITY

Double-person-derived mouse model for simulating tumor immune microenvironment and application of double-person-derived mouse model

The invention belongs to the technical field of biotechnology and animal models, and discloses a double-person-derived mouse model for simulating a tumor immune microenvironment and a construction method and application thereof. The method comprises the following steps: firstly, pretreating NSG immunodeficient mice by adopting low-dose whole-body irradiation in combination with double-antibody targeted bone marrow depletion, and transplanting CD34 + hematopoietic stem cells from the same human donor to complete human immune system reconstruction; separating tumor primary cells, tumor-related fibroblasts and tumor vascular endothelial cells of the same donor, performing three-dimensional co-culture to obtain homologous human tumor organs, and performing in-situ inoculation to immune reconstruction mice to obtain a target model. The core defects of MHC mismatching, low immune reconstruction efficiency, poor tumor immune microenvironment simulation degree, low clinical consistency and the like of an existing model are overcome, and the method can be used for tumor immune treatment drug screening, microenvironment mechanism research and personalized tumor treatment scheme verification.
Owner:GUANGDONG LAIDI BIOMEDICAL RES INST CO LTD

Construction method of model for rat traumatic brain injury caused by explosive shock waves

The invention belongs to the technical field of damage assessment, and particularly relates to a construction method of a rat traumatic brain injury model caused by explosive shock waves. By protecting other important visceral organs except the brain, interference of damage of visceral organs such as the lung to brain injury is avoided, the overall function stability of the body is maintained, the caused brain injury can more truly reflect the characteristics of explosive traumatic brain injury, and the credibility and repeatability of experimental data are improved. The construction method simulates loading of explosion shock wave parameters in a real environment, constructs an animal traumatic brain injury model through live ammunition explosion, is closer to an actual combat environment, and can truly reflect physical parameters related to explosion and a complex action process generated by interaction of the physical parameters. And a support is provided for developing molecular mechanisms of explosive traumatic brain injury, clinical diagnosis, screening of therapeutic drugs and the like.
Owner:ORDNANCE IND HYGIENIC INST

Preparation method of polygonatum sibiricum polysaccharide and application of polygonatum sibiricum polysaccharide in slow-transit constipation medicine

The invention relates to a preparation method of polygonatum sibiricum polysaccharide and application of the polygonatum sibiricum polysaccharide in a slow-transit constipation medicine, a polygonatum sibiricum raw medicinal material is used as a raw material, polygonatum sibiricum crude polysaccharide (PCP) is extracted through a water extraction and alcohol precipitation method, and a polygonatum sibiricum neutral polysaccharide homogeneous component PCNP-2 is prepared after purification. The prepared PCNP-2 has the effects of regulating intestinal flora, reducing intestinal permeability and improving lipid metabolism, is helpful for relieving gastrointestinal inflammation, diabetes and other diseases, and can be made into effective and safe STC treatment drugs. The medicine effect of the PCNP-2 can be achieved through a PI3K / AKT signal channel, and the intestinal motility weakening phenomenon of a slow transit constipation mouse model is remarkably reversed through treatment of the polygonatum polysaccharide PCNP-2.
Owner:TIANJIN MEDICAL UNIVERSITY GENERAL HOSPITAL +1

Application of intervention SNRK-MTA1 signal channel axis in preparation of non-small cell lung cancer targeted therapy drug

The invention relates to an application of an intervention SNRK-MTA1 signal channel axis in preparation of a non-small cell lung cancer targeted therapy drug. The nucleotide sequences of the mRNA of the SNRK gene and the mRNA of the MTA1 gene are respectively as shown in SEQ ID NO.1-2. The invention innovatively provides a strategy for treating the non-small cell lung cancer through double-target combined intervention. According to the strategy, SNRK gene expression is improved through exogenous gene overexpression plasmids, and meanwhile MTA1 gene expression is silenced through the siRNA technology. In a non-small cell lung cancer model, the strategy of combined application of the SNRK-OE plasmid and siMTA1 can specifically up-regulate the SNRK mRNA level and knock down the MTA1 mRNA level at the same time, and the combined strategy shows a better anti-tumor effect than single intervention, and can more effectively inhibit the growth and migration of tumor cells. Based on the discovery, the SNRK-MTA1 signal pathway axis can be developed into a novel therapeutic target for non-small cell lung cancer, and is used for designing a drug combination scheme or a composite targeted drug.
Owner:THE SECOND HOSPITAL OF SHANDONG UNIV

Anti-tumor medicine composition combined with PARG inhibitor and application

The invention discloses an anti-tumor medicine composition combined with a PARG inhibitor and application. Through natural product library screening and CCK-8 experiments, it is found that PARG knockout gastric cancer cells show significantly enhanced sensitivity to ginsenoside CK. Further clone formation experimental analysis shows that PARG knockout significantly enhances the inhibitory effect of ginsenoside CK on gastric cancer cell proliferation. In in-vivo experiments, a CDX model is utilized to verify that PARG knockout can significantly enhance the anti-tumor activity of ginsenoside CK on gastric cancer. The discovery provides an important experimental basis for clinical application of PARG as a gastric cancer treatment target and ginsenoside CK as a potential treatment drug. The research finds that the PARG inhibitor and ginsenoside CK are combined to achieve a better killing effect on other various cancer cells, and it is indicated that improvement of the effect is broad-spectrum.
Owner:HANGZHOU INSTITUTE OF MEDICAL SCIENCES CHINESE ACADEMY OF SCIENCES

Cell injury inducing therapeutic drug for use in cancer therapy

The present invention provides anticancer agents comprising as an active ingredient a bispecific antibody that comprises a domain comprising a glypican 3-binding antibody variable region, a domain comprising a T cell receptor complex-binding antibody variable region, and common L chains that can enhance the affinity for the two antigens, as well as pharmaceutical compositions comprising the bispecific antibody as an active ingredient, the compositions being for use in combination with other anticancer agents. The bispecific antibodies are novel molecules which are produced with high efficiency and have strong anti-tumor activity as well as safety and excellent pharmacodynamics. The bispecific antibodies can be expected to be applied to various cancers.
Owner:CHUGAI PHARMA CO LTD

Mouse model construction method for specifically tracing heart valve cells and application

PendingCN120796387AMicroinjection basedStable introduction of DNADiseaseHeart valve disorder
The invention discloses a construction method and application of a mouse model for specifically tracing heart valve cells, and belongs to the technical field of animal model construction. The model construction method comprises the following steps: (1) constructing a Wid1-Cre hybrid mouse before inserting a Cre recombinase coding gene into a termination codon of a mouse Wid1 gene; and (2) hybridizing the Wid1-Cre hybrid mouse with the Rosa26-tdTomato homozygous report mouse, so as to obtain the double transgenic mouse which simultaneously carries the Wid1-Cre gene and the Rosa26-tdTomato gene. According to the invention, on the basis of the expression characteristic that Wif1 is only limited to a valve area in the heart, Wif1-Cre is constructed; according to the Rosa26-tdTomato mouse model, specific tracing of heart valve cells is achieved, and an important experimental tool is provided for mechanism research of heart valve diseases and development of therapeutic drugs.
Owner:ZHEJIANG UNIV +1

Application of small-molecule inhibitor of stress particles in preparation of tumor treatment drugs

The invention discloses application of a small-molecule inhibitor of stress particles in preparation of tumor treatment drugs, and relates to the technical field of biological medicines. According to the present invention, the high throughput screening is performed on the 'ChemDiv Protein-Protein Interaction (PPI) Library', such that the small molecule inhibitor of the stress particle, i.e., the compound UA-0007373, is obtained; the research finds that the small-molecule inhibitor can effectively inhibit the formation of cell stress particles caused by G3BP1, so that the drug resistance of tumor cells is reduced. Cell experiments prove that the small-molecule inhibitor can effectively inhibit the formation of stress particles induced by anti-cancer drugs. Therefore, a brand new auxiliary compound is provided for chemical drug treatment of cancers, and a new technical thought can be provided for research and development of cancer drugs.
Owner:UNIV OF SCI & TECH OF CHINA

AAV vector targeting improving method applicable to gene therapy drugs

The invention discloses an AAV vector targeting improvement method applicable to gene therapy drugs, which comprises the following steps: performing high-throughput analysis on target tissue cells through a screening sub-module, screening candidate receptor genes interacting with AAV vector targeting molecules, and determining target receptor genes; the selection submodule is used for designing a gene editing system and selecting a promoter with tissue specific expression to drive the expression of the gene editing system; the introduction submodule is used for introducing the gene editing system into target tissue cells by adopting a gene transfer technology; and the evaluation sub-module is used for selecting the most suitable gene transfer mode according to the characteristics and treatment requirements of the target tissue, and detecting and evaluating the cells subjected to gene editing by utilizing a PCR molecular biological technology. The targeting property of the AAV vector to target tissue cells is improved, the infection of non-target tissues is reduced, and the side effect risk is reduced, so that the gene therapy effect is remarkably improved.
Owner:SUZHOU GEDING BIOTECHNOLOGY CO LTD

Biomarker for sepsis encephalopathy and application thereof

The invention provides a biomarker for sepsis encephalopathy and application of the biomarker. The biomarker is selected from any one or a combination of more than two of 5-HTP, 5-HIAA or 5-HIAA / 5-HT according to a ratio of 5-HTP to 5-HIAA to 5-HT. The biomarker has the advantages of high sensitivity and high precision, and development and utilization of the key biomarker have important value in precise diagnosis, prognosis, subsequent treatment and drug screening of sepsis encephalopathy.
Owner:PEKING UNION MEDICAL COLLEGE HOSPITAL